1

186

W (28.6%)

74

+ n

g

+

T

1/2

-

b

187

W

74

= 23.72h

187

Re*

75

~

T

1/2

< 1ms

g

187

Re

75

479.53 keV (21.8%)

685.77 keV (27.3%)

618.36 keV (6.3%)

{

(T

1/2

10

= 4.35 10 y)

2

55

Mn (100%)

25

+ n

T

1/2

-

b

= 2.58h

56

Fe*

26

~

T

1/2

< 6ps

g

846.77 keV (100%)

2113.12 keV (14.3%)

1810.77 keV (27.2%)

{

(stable)

56

Fe

26

3

27

Al (100%)

13

+ n

T

1/2

-

b

= 2.24m

~

T

1/2

< 1ps

g

1778.96 keV (100%)

(stable)

28

Al

13

56

Mn

25

28

Al

13

28

Si*

14

28

Si

14

4

58

Ni (68.1%)

28

+ g

T

1/2

+

EC+

b

= 35.6h

~

T

1/2

< 200ps

g

1377.63 keV (81.7%)

57

Co*

27

57

Co

27

57

Ni

28

+

EC+

b

T

1/2

= 271.79d

57

Fe*

26

57

Fe

26

(stable)

g

122.06 keV (85.6%)

T

1/2

100ns

<

~

g

+

g

+

n +

197

Au (100%)

79

T

1/2

-

b

= 6.183d

~

T

1/2

< 15ps

g

426.09 keV (100%)

(stable)

196

Au

79

196

Hg*

80

7

g

e

g

’,n

+

e’,n

196

Hg

80

T

1/2

+

EC+

b

= 6.183d

~

T

1/2

< 40ps

g

355.68 keV (87%)

(stable)

196

Pt*

78

196

Pt

78

332.98 keV (23%)

7%

93%

8

g

+

+ n

197.14 keV (95.9%)

g

T

1/2

< 100ns

T

1/2

-

b

= 26.9s

19

F*

9

19

O

8

18

O (0.2%)

8

19

F

9

73

Ge (7.7%)

32

+ n

g

+

74

Ge

32

9

74

Ge (36%)

32

+ n

n +

74

Ge*

32

595.85 keV

g

~

T

1/2

< 12ps

74

Ge

32

608.35 keV

{

{

{

10

70

Ge (21%)

32

+ n

g

+

71

Ge

32

174.95 keV

867.89 keV

+ n

6

113

Cd (12.2%)

48

114

Cd

48

(stable)

558.45 keV

g

+

37

Cl (24.23%)

17

38

Ar*

18

T

1/2

-

b

= 37.24m

T

1/2

< 0.5ns

g

2167.41 keV (42.4%)

1642.71 keV (31.9%)

{

+ n

38

Cl

17

5

38

Ar

18

(stable)

g

+

(stable)

(stable)

T

1/2

+

EC+

b

= 11.43d

71

Ga

31

(stable)

11

1

H (100%)

1

+ n

g

+

2

H

1

2224.57 keV

(stable)

Niepożądane reakcje zachodzące

w trakcie emisji akceleratorowych

wiązek terapeutycznych